Vaccines, blood, antisera, toxins and cultures in Japan 2020 Exports | Imports : $3.08B | $7.9B, World Rnk 14 / 193 Rnk 47 / 1207 | World Rnk 8 / 221 Rnk 12 / 1206
2019 - 2020 FASTEST GROWING MARKET | FASTEST GROWING ORIGIN: $981M | $916M, United States | United States
2020 ECONOMIC COMPLEXITY of Japan: 2.19, Rnk 1 / 127
2020 PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures: 1.23, Rnk 112 / 1029
Exports In 2020, Japan exported $3.08B in Vaccines, blood, antisera, toxins and cultures, making it the 14th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 47th most exported product in Japan. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Japan are: Switzerland ($1.12B), United States ($1.04B), Germany ($189M), United Kingdom ($115M), and China ($114M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Japan between 2019 and 2020 were United States ($981M), Switzerland ($711M), and South Korea ($35.1M).
Imports In 2020, Japan imported $7.9B in Vaccines, blood, antisera, toxins and cultures, becoming the 8th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 12th most imported product in Japan. Japan imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($2.22B), Ireland ($1.73B), Switzerland ($1.55B), Germany ($1.09B), and Belgium ($241M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Japan between 2019 and 2020 were United States ($916M), Switzerland ($162M), and South Korea ($83.6M).
October 2022
Overview In October 2022 Japan's Vaccines, blood, antisera, toxins and cultures exports accounted up to ¥31.3B and imports accounted up to ¥350B, resulting in a negative trade balance of ¥319B. Between October 2021 and October 2022 the exports of Japan's Vaccines, blood, antisera, toxins and cultures have increased by ¥4.16B (15.4%) from ¥27.1B to ¥31.3B, while imports increased by ¥198B (130%) from ¥153B to ¥350B.
Destinations In October 2022, Vaccines, blood, antisera, toxins and cultures were exported mostly to Switzerland (Â¥21.4B), Germany (Â¥2.77B), United Kingdom (Â¥2.65B), United States (Â¥1.2B), and South Korea (Â¥792M), and were imported mostly from Belgium (Â¥164B), United States (Â¥62.7B), Ireland (Â¥46.9B), Switzerland (Â¥20.1B), and Germany (Â¥17.2B).
Growth In October 2022, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to United States (Â¥6.49B or 925%), Germany (Â¥1.04B or 111%), and China (Â¥304M or 35.8%). In October 2022, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Ireland (Â¥15.2B or 68.1%), Belgium (Â¥3.32B or 190%), and Puerto Rico (Â¥1.25B or 98.1%).
EXPORT GROWTH (October 2021 - October 2022): ¥4.16B, (15.4%)
IMPORT GROWTH (October 2021 - October 2022): ¥198B, (130%)
MAIN EXPORTER (October 2022): Chiba, ¥25.4B
MAIN DESTINATION (October 2022): Switzerland, ¥21.4B
This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Japan. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.
For full datasets download visit Bulk Download page.
EXPORTS (2020): $3.08B
IMPORTS (2020): $7.9B
NET TRADE (2020): -$4.82B
In 2020, Japan exported $3.08B in Vaccines, blood, antisera, toxins and cultures. The main destinations of Japan exports on Vaccines, blood, antisera, toxins and cultures were Switzerland ($1.12B), United States ($1.04B), Germany ($189M), United Kingdom ($115M), and China ($114M).
In 2020, Japan imported $7.9B in Vaccines, blood, antisera, toxins and cultures, mainly from United States ($2.22B), Ireland ($1.73B), Switzerland ($1.55B), Germany ($1.09B), and Belgium ($241M).
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Japan WERE (2019 - 2020):
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Japan WERE (2019 - 2020):
In 2020, Japan's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2020, Japan's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:
Have questions, comments, or concerns?
Send us an e-mail: [email protected]
v5.1.12 jaguar